How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.
Identifieur interne : 001D00 ( PubMed/Checkpoint ); précédent : 001C99; suivant : 001D01How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.
Auteurs : Josep M. Borras [Espagne] ; Yolande Lievens [Belgique] ; Michael Barton [Australie] ; Julieta Corral [Espagne] ; Jacques Ferlay [France] ; Freddie Bray [France] ; Cai Grau [Danemark]Source :
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [ 1879-0887 ] ; 2016.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- epidemiology : Europe, Neoplasms.
- radiotherapy : Neoplasms.
- statistics & numerical data : Databases, Factual.
- Australia, Female, Forecasting, Humans, Incidence, Male.
Abstract
The objective of this HERO study was to assess the number of new cancer patients that will require at least one course of radiotherapy by 2025.
DOI: 10.1016/j.radonc.2016.02.016
PubMed: 26922487
Affiliations:
- Australie, Belgique, Danemark, Espagne, France
- Auvergne-Rhône-Alpes, Catalogne, Rhône-Alpes
- Barcelone, Lyon
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:26922487Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.</title><author><name sortKey="Borras, Josep M" sort="Borras, Josep M" uniqKey="Borras J" first="Josep M" last="Borras">Josep M. Borras</name><affiliation wicri:level="3"><nlm:affiliation>University of Barcelona, IDIBELL, Barcelona, Spain. Electronic address: jmborras@ub.edu.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>University of Barcelona, IDIBELL, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Lievens, Yolande" sort="Lievens, Yolande" uniqKey="Lievens Y" first="Yolande" last="Lievens">Yolande Lievens</name><affiliation wicri:level="1"><nlm:affiliation>Radiation Oncology Department, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Radiation Oncology Department, Ghent University Hospital, Ghent</wicri:regionArea><wicri:noRegion>Ghent</wicri:noRegion></affiliation></author><author><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name><affiliation wicri:level="1"><nlm:affiliation>CCORE Ingham Institute for Applied Medical Research, University of South New Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>CCORE Ingham Institute for Applied Medical Research, University of South New Wales</wicri:regionArea><wicri:noRegion>University of South New Wales</wicri:noRegion></affiliation></author><author><name sortKey="Corral, Julieta" sort="Corral, Julieta" uniqKey="Corral J" first="Julieta" last="Corral">Julieta Corral</name><affiliation wicri:level="3"><nlm:affiliation>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name><affiliation wicri:level="3"><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name><affiliation wicri:level="3"><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Grau, Cai" sort="Grau, Cai" uniqKey="Grau C" first="Cai" last="Grau">Cai Grau</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Oncology, Aarhus University Hospital, Aarhus</wicri:regionArea><wicri:noRegion>Aarhus</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:26922487</idno><idno type="pmid">26922487</idno><idno type="doi">10.1016/j.radonc.2016.02.016</idno><idno type="wicri:Area/PubMed/Corpus">002054</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002054</idno><idno type="wicri:Area/PubMed/Curation">002029</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002029</idno><idno type="wicri:Area/PubMed/Checkpoint">002029</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002029</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.</title><author><name sortKey="Borras, Josep M" sort="Borras, Josep M" uniqKey="Borras J" first="Josep M" last="Borras">Josep M. Borras</name><affiliation wicri:level="3"><nlm:affiliation>University of Barcelona, IDIBELL, Barcelona, Spain. Electronic address: jmborras@ub.edu.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>University of Barcelona, IDIBELL, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Lievens, Yolande" sort="Lievens, Yolande" uniqKey="Lievens Y" first="Yolande" last="Lievens">Yolande Lievens</name><affiliation wicri:level="1"><nlm:affiliation>Radiation Oncology Department, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Radiation Oncology Department, Ghent University Hospital, Ghent</wicri:regionArea><wicri:noRegion>Ghent</wicri:noRegion></affiliation></author><author><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name><affiliation wicri:level="1"><nlm:affiliation>CCORE Ingham Institute for Applied Medical Research, University of South New Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>CCORE Ingham Institute for Applied Medical Research, University of South New Wales</wicri:regionArea><wicri:noRegion>University of South New Wales</wicri:noRegion></affiliation></author><author><name sortKey="Corral, Julieta" sort="Corral, Julieta" uniqKey="Corral J" first="Julieta" last="Corral">Julieta Corral</name><affiliation wicri:level="3"><nlm:affiliation>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona</wicri:regionArea><placeName><settlement type="city">Barcelone</settlement><region nuts="2" type="region">Catalogne</region></placeName></affiliation></author><author><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name><affiliation wicri:level="3"><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name><affiliation wicri:level="3"><nlm:affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author><author><name sortKey="Grau, Cai" sort="Grau, Cai" uniqKey="Grau C" first="Cai" last="Grau">Cai Grau</name><affiliation wicri:level="1"><nlm:affiliation>Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.</nlm:affiliation><country xml:lang="fr">Danemark</country><wicri:regionArea>Department of Oncology, Aarhus University Hospital, Aarhus</wicri:regionArea><wicri:noRegion>Aarhus</wicri:noRegion></affiliation></author></analytic><series><title level="j">Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</title><idno type="eISSN">1879-0887</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Australia</term><term>Databases, Factual (statistics & numerical data)</term><term>Europe (epidemiology)</term><term>Female</term><term>Forecasting</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Neoplasms (epidemiology)</term><term>Neoplasms (radiotherapy)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Australie</term><term>Bases de données factuelles ()</term><term>Europe (épidémiologie)</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Prévision</term><term>Tumeurs (radiothérapie)</term><term>Tumeurs (épidémiologie)</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Europe</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Databases, Factual</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Europe</term><term>Tumeurs</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Australia</term><term>Female</term><term>Forecasting</term><term>Humans</term><term>Incidence</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Australie</term><term>Bases de données factuelles</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mâle</term><term>Prévision</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The objective of this HERO study was to assess the number of new cancer patients that will require at least one course of radiotherapy by 2025.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26922487</PMID><DateCreated><Year>2016</Year><Month>04</Month><Day>26</Day></DateCreated><DateCompleted><Year>2017</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2017</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0887</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>04</Month></PubDate></JournalIssue><Title>Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology</Title><ISOAbbreviation>Radiother Oncol</ISOAbbreviation></Journal><ArticleTitle>How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.</ArticleTitle><Pagination><MedlinePgn>5-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.radonc.2016.02.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0167-8140(16)00074-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">The objective of this HERO study was to assess the number of new cancer patients that will require at least one course of radiotherapy by 2025.</AbstractText><AbstractText Label="METHODS">European cancer incidence data by tumor site and country for 2012 and 2025 was extracted from the GLOBOCAN database. The projection of the number of new cases took into account demographic factors (age and size of the population). Population based stages at diagnosis were taken from four European countries. Incidence and stage data were introduced in the Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) model.</AbstractText><AbstractText Label="RESULTS">Among the different tumor sites, the highest expected relative increase by 2025 in treatment courses was prostate cancer (24%) while lymphoma (13%), head and neck (12%) and breast cancer (10%) were below the average. Based on the projected cancer distributions in 2025, a 16% expected increase in the number of radiotherapy treatment courses was estimated. This increase varied across European countries from less than 5% to more than 30%.</AbstractText><AbstractText Label="CONCLUSION">With the already existing disparity in radiotherapy resources in mind, the data provided here should act as a leverage point to raise awareness among European health policy makers of the need for investment in radiotherapy.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Borras</LastName><ForeName>Josep M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>University of Barcelona, IDIBELL, Barcelona, Spain. Electronic address: jmborras@ub.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lievens</LastName><ForeName>Yolande</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Radiation Oncology Department, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barton</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CCORE Ingham Institute for Applied Medical Research, University of South New Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corral</LastName><ForeName>Julieta</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Catalan Cancer Strategy, Department of Health, Generalitat de Catalunya, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferlay</LastName><ForeName>Jacques</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bray</LastName><ForeName>Freddie</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Section of Cancer Surveillance, International Agency for Research on Cancer (IARC), Lyon, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grau</LastName><ForeName>Cai</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Radiother Oncol</MedlineTA><NlmUniqueID>8407192</NlmUniqueID><ISSNLinking>0167-8140</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">European countries</Keyword><Keyword MajorTopicYN="N">Optimal utilization</Keyword><Keyword MajorTopicYN="N">Projections</Keyword><Keyword MajorTopicYN="N">Radiotherapy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>02</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>2</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26922487</ArticleId><ArticleId IdType="pii">S0167-8140(16)00074-8</ArticleId><ArticleId IdType="doi">10.1016/j.radonc.2016.02.016</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Australie</li><li>Belgique</li><li>Danemark</li><li>Espagne</li><li>France</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Catalogne</li><li>Rhône-Alpes</li></region><settlement><li>Barcelone</li><li>Lyon</li></settlement></list><tree><country name="Espagne"><region name="Catalogne"><name sortKey="Borras, Josep M" sort="Borras, Josep M" uniqKey="Borras J" first="Josep M" last="Borras">Josep M. Borras</name></region><name sortKey="Corral, Julieta" sort="Corral, Julieta" uniqKey="Corral J" first="Julieta" last="Corral">Julieta Corral</name></country><country name="Belgique"><noRegion><name sortKey="Lievens, Yolande" sort="Lievens, Yolande" uniqKey="Lievens Y" first="Yolande" last="Lievens">Yolande Lievens</name></noRegion></country><country name="Australie"><noRegion><name sortKey="Barton, Michael" sort="Barton, Michael" uniqKey="Barton M" first="Michael" last="Barton">Michael Barton</name></noRegion></country><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Ferlay, Jacques" sort="Ferlay, Jacques" uniqKey="Ferlay J" first="Jacques" last="Ferlay">Jacques Ferlay</name></region><name sortKey="Bray, Freddie" sort="Bray, Freddie" uniqKey="Bray F" first="Freddie" last="Bray">Freddie Bray</name></country><country name="Danemark"><noRegion><name sortKey="Grau, Cai" sort="Grau, Cai" uniqKey="Grau C" first="Cai" last="Grau">Cai Grau</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D00 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001D00 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:26922487
|texte= How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:26922487" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |